论文信息 - Blood‐based detection of RAS mutations to guide anti‐EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue‐based RAS testing - 字舞流文

Blood‐based detection of RAS mutations to guide anti‐EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue‐based RAS testing

S. Fox | H. Friess | R. Scott | J. Slotta-Huspenina | W. Uhl | C. Meldrum | W. Schmiegel | A. Tannapfel | S. Hahn | R. Viebahn | B. Dockhorn‐Dworniczak | K. Janssen | A. Baraniskin | U. Nitsche | H. Wolters | D. Vangala | W. Lewis | A. Reinacher-Schick | C. Hewitt | S. Hegewisch‐Becker | D. Edelstein | F. Jones | B. Draganic | M. Pohl | P. Pockney | C. Teschendorf | T. Chan | P. Ronga | S. Dooley | Steve Smith | Hazel Philimore | Amanda Lucas | E. Shi | Kateh Namdarian | D. Acosta | Sun Ping-chang | J. Stern | R. Scott | R. Scott | Susan Dooley | Peter Pockney